CALABRESI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 53.119
EU - Europa 2.787
AS - Asia 715
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 14
OC - Oceania 4
AF - Africa 3
Totale 56.662
Nazione #
US - Stati Uniti d'America 53.108
UA - Ucraina 829
DE - Germania 498
CN - Cina 487
IE - Irlanda 465
SE - Svezia 227
FR - Francia 172
FI - Finlandia 159
IT - Italia 159
KR - Corea 157
GB - Regno Unito 128
RU - Federazione Russa 73
PL - Polonia 48
JP - Giappone 26
EU - Europa 19
KG - Kirghizistan 12
NL - Olanda 11
IN - India 8
CL - Cile 7
CA - Canada 6
BR - Brasile 5
AU - Australia 4
DM - Dominica 4
IR - Iran 4
SG - Singapore 4
BE - Belgio 3
DK - Danimarca 3
NG - Nigeria 3
UZ - Uzbekistan 3
AR - Argentina 2
CH - Svizzera 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
GR - Grecia 1
HK - Hong Kong 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MF - Saint Martin 1
MT - Malta 1
MY - Malesia 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 56.662
Città #
Woodbridge 17.722
Wilmington 14.503
Houston 12.876
Fairfield 1.675
Ann Arbor 1.322
Jacksonville 774
Ashburn 650
Seattle 627
Cambridge 574
Dublin 465
Chandler 408
Medford 327
Beijing 198
Lawrence 160
Zhengzhou 117
New York 114
Mülheim 112
Menlo Park 102
Dearborn 82
San Diego 56
Kraków 46
University Park 39
San Mateo 37
Rome 35
Mcallen 32
Milan 31
Hefei 29
Mountain View 29
Falls Church 26
Shanghai 25
Verona 25
Saint Petersburg 24
Nanjing 21
Redwood City 19
Detroit 18
Guangzhou 18
Palo Alto 18
Norwalk 17
London 15
Monmouth Junction 12
Redmond 12
Nanchang 10
Indiana 9
Kunming 9
Hangzhou 7
Jinan 6
San Francisco 6
Florence 5
Groningen 5
Prescot 5
Boardman 4
Chicago 4
Fuzhou 4
Kilburn 4
New Bedfont 4
Roseau 4
Simi Valley 4
São Paulo 4
Tokyo 4
Toronto 4
Wandsworth 4
Brussels 3
Changsha 3
Chengdu 3
Hounslow 3
Mantova 3
Perugia 3
Riccione 3
Shenyang 3
Augusta 2
Bari 2
Bengaluru 2
Birmingham 2
Bonn 2
Chiyoda-ku 2
Creede 2
Frederiksberg 2
Hanoi 2
Hebei 2
Kathmandu 2
La Spezia 2
Lausanne 2
Liverpool 2
Locorotondo 2
Moscow 2
Muenster 2
Naples 2
Napoli 2
Pizzo 2
Shaoxing 2
Acton 1
Almaty 1
Athens 1
Atlanta 1
Auburn Hills 1
Bangalore 1
Berlin 1
Boston 1
Bratislava 1
Braunschweig 1
Totale 53.574
Nome #
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 443
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 441
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 431
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 427
Muscarinic IPSPs in rat striatal cholinergic interneurones 426
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 425
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 422
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 421
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 418
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 414
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 411
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 410
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 408
Synaptic transmission in the striatum: from plasticity to neurodegeneration 406
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 406
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 405
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 399
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 399
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 398
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 395
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 395
Role of Ca2+ in striatal LTD and LTP 395
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 394
Removing pathogenic memories: a neurobiology of psychotherapy 393
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 393
Unilateral dopamine denervation blocks corticostriatal LTP 392
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 390
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases 390
Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors 390
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 390
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism 390
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 389
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 389
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 388
Dopaminergic control of synaptic plasticity in the dorsal striatum 388
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 388
Deficits of glutamate transmission in the striatum of experimental hemiballism 387
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 387
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 387
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 386
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 385
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 385
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 385
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 385
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 385
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 384
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 384
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum 384
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 384
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 384
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 384
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 383
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 383
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease 383
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 382
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings 382
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 382
Permissive role of interneurons in corticostriatal synaptic plasticity 381
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 380
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease 380
Synaptic plasticity in the ischaemic brain 380
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease 378
Hyperkinetic disorders and loss of synaptic downscaling 378
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 376
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 375
Tissue plasminogen activator is required for corticostriatal long-term potentiation 374
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 374
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 374
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 371
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 370
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 369
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 369
Chronic cocaine prevents depotentiation at corticostriatal synapses 368
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms 368
NR2B subunit exerts a critical role in postischemic synaptic plasticity 367
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 367
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 367
The modulation of dopamine receptors in rat striatum 366
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 365
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 365
The modulation of calcium currents by the activation of mGluRs. Functional implications 360
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 359
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 359
Glutamate-triggered events inducing corticostriatal long-term depression 358
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 356
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 356
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 353
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 353
Basic research in substantia nigra and ventral tegmental area: clinical implications 353
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 352
Selective involvement of mGlu1 receptors in corticostriatal LTD 351
Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum 351
Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum 351
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons 350
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 350
Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons 350
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression 350
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery 349
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones 349
Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese 347
Totale 38.249
Categoria #
all - tutte 91.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.474 0 0 0 0 0 0 0 0 0 0 1.777 1.697
2019/202015.661 1.408 1.406 1.267 1.446 1.226 1.678 1.216 1.429 1.285 1.175 981 1.144
2020/20218.340 898 1.132 885 1.102 879 734 1.128 767 207 139 343 126
2021/20221.282 35 71 35 98 16 201 34 51 72 195 38 436
2022/20231.437 190 77 27 138 84 423 157 80 93 4 135 29
2023/2024284 32 13 37 8 32 113 15 27 2 5 0 0
Totale 56.822